Clinical Trials Browser

Phase 3 × Recurrence × Cetuximab × Clear all

NCT06064877 2025-04-13

FIERCE-HN

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence

NCT01309126 2017-07-13

PRIMUS

Phase 3 Terminated

Gastrointestinal

Recurrence, Colorectal Neoplasms

NCT00095199 2012-10-15

Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer

Phase 3 Completed

939 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung, Recurrence